Gennova Biopharmaceuticals’ Covid-19 mRNA vaccine is expected not only to achieve similar efficacy to the candidates developed by Pfizer and Moderna, but also to be more affordable for a country like India, according to CEO Dr. Sanjay Singh. How does your mRNA vaccine, which uses a self-amplification model, compare to …
Read More »‘The price of the vaccine will be a result of scale; have a production capacity of 30 million doses per month ‘
